Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...

・The FDA issued a complete response letter regarding the application for RP1 in combination with Nivolumab for the treatment of advanced melanoma in late July. ・Following months of engagement between ...

Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all ...

Learning JavaScript goes beyond tutorials — it’s about creating interactive, real-world projects that sharpen your skills and build your portfolio. From DOM manipulation to API integration, hands-on ...

Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates ...

The top video conferencing services we've tested help you stay connected and communicate with clients, team members, and anyone else, no matter where you are. I've been writing about technology for ...

One of the easiest ways to save a webpage is to save it as a PDF. Converting a webpage into PDF makes important documents immediately accessible, like receipts or any page that you may not be able to ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.